ATE516817T1 - Impfstoffe zur immunisierung gegen helicobacter - Google Patents

Impfstoffe zur immunisierung gegen helicobacter

Info

Publication number
ATE516817T1
ATE516817T1 AT06754304T AT06754304T ATE516817T1 AT E516817 T1 ATE516817 T1 AT E516817T1 AT 06754304 T AT06754304 T AT 06754304T AT 06754304 T AT06754304 T AT 06754304T AT E516817 T1 ATE516817 T1 AT E516817T1
Authority
AT
Austria
Prior art keywords
vaccines
immunization against
against helicobacter
helicobacter
immunization
Prior art date
Application number
AT06754304T
Other languages
English (en)
Inventor
Richard Ducatelle
Ann Hellemans
Original Assignee
Univ Gent
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Gent filed Critical Univ Gent
Application granted granted Critical
Publication of ATE516817T1 publication Critical patent/ATE516817T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT06754304T 2005-06-16 2006-06-12 Impfstoffe zur immunisierung gegen helicobacter ATE516817T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US69139405P 2005-06-16 2005-06-16
US69599505P 2005-07-01 2005-07-01
PCT/EP2006/005616 WO2006133879A2 (en) 2005-06-16 2006-06-12 Vaccines for immunization against helicobacter

Publications (1)

Publication Number Publication Date
ATE516817T1 true ATE516817T1 (de) 2011-08-15

Family

ID=37309206

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06754304T ATE516817T1 (de) 2005-06-16 2006-06-12 Impfstoffe zur immunisierung gegen helicobacter

Country Status (9)

Country Link
US (1) US7780951B2 (de)
EP (1) EP1896067B1 (de)
JP (1) JP2008546658A (de)
AR (1) AR054477A1 (de)
AT (1) ATE516817T1 (de)
AU (1) AU2006257383A1 (de)
CA (1) CA2612271A1 (de)
TW (1) TW200800255A (de)
WO (1) WO2006133879A2 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008546658A (ja) 2005-06-16 2008-12-25 ウニヴァシテイト ゲント ヘリコバクターに対する免疫化のためのワクチン
US7790143B2 (en) 2005-06-16 2010-09-07 Universiteit Gent Vaccines for immunization against helicobacter
WO2008085549A2 (en) * 2006-07-28 2008-07-17 Board Of Regents Of The University Of Texas System Compositions and methods for stimulation of lung innate immunity
MX2009004922A (es) * 2006-11-14 2009-05-19 Univ Gent Cultivo in vitro de especies helicobacter.
US7939079B2 (en) 2006-11-14 2011-05-10 Universiteit Gent Helicobacter species and cultivation thereof
GB0807305D0 (en) * 2008-04-22 2008-05-28 Univ Ghent Compounds for use in therapy
GB0807306D0 (en) * 2008-04-22 2008-05-28 Univ Ghent Adjuvants for use in vaccination
US20110105383A1 (en) * 2008-09-10 2011-05-05 Magnus Hook Methods and compositions for stimulation of mammalian innate immune resistance to pathogens
PL2411521T3 (pl) 2009-03-25 2015-08-31 Univ Texas Kompozycje do stymulacji wrodzonej odporności immunologicznej na patogeny u ssaków
CN102884079B (zh) * 2010-08-03 2014-12-10 华肝基因股份有限公司 治疗肝炎病毒感染的组合物及方法
US11951139B2 (en) 2015-11-30 2024-04-09 Seed Health, Inc. Method and system for reducing the likelihood of osteoporosis
US11951140B2 (en) 2011-02-04 2024-04-09 Seed Health, Inc. Modulation of an individual's gut microbiome to address osteoporosis and bone disease
US11844720B2 (en) 2011-02-04 2023-12-19 Seed Health, Inc. Method and system to reduce the likelihood of dental caries and halitosis
WO2014201525A1 (en) * 2013-06-21 2014-12-24 Ondek Pty Ltd Immunotherapy composition and use thereof
US11980643B2 (en) 2013-12-20 2024-05-14 Seed Health, Inc. Method and system to modify an individual's gut-brain axis to provide neurocognitive protection
US11833177B2 (en) 2013-12-20 2023-12-05 Seed Health, Inc. Probiotic to enhance an individual's skin microbiome
US11839632B2 (en) 2013-12-20 2023-12-12 Seed Health, Inc. Topical application of CRISPR-modified bacteria to treat acne vulgaris
US11969445B2 (en) 2013-12-20 2024-04-30 Seed Health, Inc. Probiotic composition and method for controlling excess weight, obesity, NAFLD and NASH
US11826388B2 (en) 2013-12-20 2023-11-28 Seed Health, Inc. Topical application of Lactobacillus crispatus to ameliorate barrier damage and inflammation
US10286065B2 (en) 2014-09-19 2019-05-14 Board Of Regents, The University Of Texas System Compositions and methods for treating viral infections through stimulated innate immunity in combination with antiviral compounds

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8205892D0 (sv) 1982-10-18 1982-10-18 Bror Morein Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin
SE8405493D0 (sv) 1984-11-01 1984-11-01 Bror Morein Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel
ATE71303T1 (de) 1986-01-14 1992-01-15 Nederlanden Staat Verfahren zur herstellung immunologischer komplexe und diese enthaltende pharmazeutische zusammensetzung.
MX9301706A (es) * 1992-04-13 1994-05-31 Oravax Inc Composicion de vacuna para el tratamiento de la infeccion por helicobacter.
WO1995014093A1 (en) * 1993-05-19 1995-05-26 Institut Pasteur Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions and nucleic acid sequences encoding said polypeptides
US6258359B1 (en) * 1993-05-19 2001-07-10 Institut Pasteur Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions, and nucleic acid sequences encoding said polypeptides
HUE026171T2 (en) 2003-02-03 2016-05-30 Cerebus Biologicals Inc A method for treating, preventing and detecting Helicobacter infection
DE102005025467A1 (de) 2005-06-02 2006-12-07 Westfaliasurge Gmbh Verfahren zum Melken von Tieren in einer Gruppe
JP2008546658A (ja) 2005-06-16 2008-12-25 ウニヴァシテイト ゲント ヘリコバクターに対する免疫化のためのワクチン

Also Published As

Publication number Publication date
EP1896067B1 (de) 2011-07-20
AU2006257383A1 (en) 2006-12-21
WO2006133879A2 (en) 2006-12-21
JP2008546658A (ja) 2008-12-25
CA2612271A1 (en) 2006-12-21
TW200800255A (en) 2008-01-01
WO2006133879A3 (en) 2007-07-26
AR054477A1 (es) 2007-06-27
US20060292179A1 (en) 2006-12-28
US7780951B2 (en) 2010-08-24
EP1896067A2 (de) 2008-03-12

Similar Documents

Publication Publication Date Title
ATE516817T1 (de) Impfstoffe zur immunisierung gegen helicobacter
ATE462445T1 (de) Prrs-impfstoffe
DK1968631T3 (da) Vaccine
ATE516044T1 (de) Attenuierte rotavirus-vakzine zur oralen verabreichung
HK1218427A1 (zh) 改進的疫苗及其使用方法
ATE450271T1 (de) Impfstoff
EP1917040A4 (de) Polyvalenter impfstoff
BRPI0814594A2 (pt) Composições e métodos adjuvantes de antígeno
DK1959991T3 (da) Terapeutisk vaccine
GB0504436D0 (en) Vaccine
DK1896065T3 (da) Fremgangsmåde til fremstilling af vacciner
MA28609B1 (fr) Vaccins
CR10571A (es) Vacuna virica recombinante
MA28639B1 (fr) Vaccins
BRPI0607474A2 (pt) vacinação enriquecida com glicosido-alquila
MA28885B1 (fr) vaccins
DE602006003359D1 (de) Gerät zur optischen Tomographie
GB0515135D0 (en) Vaccine
ZA200709207B (en) Vaccine
GB0516944D0 (en) Vaccine
GB0810662D0 (en) Vaccine
ZA200709210B (en) Vaccine
GB0526412D0 (en) Vaccine
IL186586A0 (en) Vaccine
IL186591A0 (en) Vaccine

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties